MATERIALS AND METHODS
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment.J Urol. 2015; 193: 1572-1580
- Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder.Neurourol Urodyn. 2015; 34: 224-230
- Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study).Eur Urol. 2012; 62: 507-514
- OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.Eur Urol. 2013; 64: 249-256
- Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging study.Eur Urol. 2012; 61: 520-529
- Neuromodulation for chronic pelvic pain.Curr Urol Rep. 2018; 19: 32
- Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial.J Urol. 2010; 184: 2001-2006
- Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study.J Urol. 2001; 165: 1193-1198
- Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder.J Urol. 2010; 183: 234-240
- Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial.J Urol. 2010; 183: 1438-1443
- Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity.World J Urol. 2011; 29: 51-57
- Disseminating innovations in health care.JAMA. 2003; 289: 1969-1975
- Posterior tibial nerve stimulation in patients who have failed anticholinergic therapy: efficacy and time to response.Female Pelvic Med Reconstr Surg. 2011; 17: 74-75
- Percutaneous Tibial nerve stimulation in the office setting: real-world experience of over 100 patients.Urology. 2018; 113: 34-39
- Surgeon characteristics and long-term trends in the adoption of laparoscopic radical nephrectomy.J Urol. 2011; 185: 2072-2077
- Adoption of prebiopsy magnetic resonance imaging for men undergoing prostate biopsy in the United States.Urology. 2018; 117: 57-63
- Lessons from a patient experience survey in a randomized surgical trial of treatment of stress urinary incontinence in women.Int Urogynecol J. 2011; 22: 1273-1278
- The effect of HMOs on the inpatient utilization of medicare beneficiaries.Health Serv Res. 2004; 39: 1607-1627
- Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder.Urology. 2010; 76: 835-840
- Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of care.Curr Urol Rep. 2012; 13: 327-334
- Satisfaction and patient experience with sacral neuromodulation: results of a single center sample survey.J Urol. 2011; 185: 588-592
- Racial and ethnic disparities in US health care.Lancet. 2003; 362: 1674
- Efficacy of percutaneous tibial nerve stimulation (PTNS) for overactive bladder in women and men at a safety-net hospital.J Urol. 2020; 203: 385-391
- Feasibility of a fully implanted, nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence.J Urol. 2019; 201: 967-972
Funding Support: Dr. Filson was supported by the American Cancer Society during the time frame of this study (MRSG-18-015-01-CPHPS).
Author Contributions: Concept and design: Jiang, Hammett, Filson; Acquisition, analysis, or interpretation of data: All authors, led by Patil; Drafting of manuscript: Jiang, Filson; Critical revision of the manuscript for important intellectual content: All authors; Statistical analysis: Patil, Filson; Administrative, technical, or material support: Hammett, Filson; Supervision: Hammett, Filson.